切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2023, Vol. 13 ›› Issue (03) : 129 -133. doi: 10.3877/cma.j.issn.2095-2007.2023.03.001

述评

关注数字疗法在眼健康领域的应用
李其鑫, 陈蔚()   
  1. 325027 温州医科大学附属眼视光医院2021级博士研究生
    325027 温州医科大学附属眼视光医院 国家耳鼻喉疾病临床医学研究中心(眼部疾病)
  • 收稿日期:2022-12-07 出版日期:2023-06-28
  • 通信作者: 陈蔚
  • 基金资助:
    国家重点研发计划项目(2019YFC0840708)

Pay attention to the application of digital therapy in the field of eye health

Qixin Li, Wei Chen()   

  1. Doctor′s degree 2021, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
    National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
  • Received:2022-12-07 Published:2023-06-28
  • Corresponding author: Wei Chen
引用本文:

李其鑫, 陈蔚. 关注数字疗法在眼健康领域的应用[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 129-133.

Qixin Li, Wei Chen. Pay attention to the application of digital therapy in the field of eye health[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2023, 13(03): 129-133.

近年来,眼健康问题日益突出,近视、斜弱视及其他常见致盲性眼病的患病率不断上升,而治疗依从性和院外管理欠佳。数字疗法(DTx)是一种基于循证医学的远程干预措施,主要以软件的形式用于疾病的预防、治疗或管理。数字疗法与眼健康领域的结合,有助于实现远程治疗视功能障碍性眼病、院外管理慢性眼病等,以弥补日益增长的维护眼健康需求。本文中笔者对数字疗法及其在眼健康领域应用的相关研究进行述评。

In recent years, eye health issues have become increasingly prominent, with the prevalence of myopia, strabismus and other common blinding eye diseases rising, while treatment compliance and out-of-hospital management are poor. Digital therapeutics (DTx) is an evidence-based remote intervention, mainly in the form of software, for the prevention, treatment or management of disease. The combination of DTx and the field of eye health is of great benefit for the remote treatment of visually dysfunctional eye diseases and the out-of-hospital management of chronic eye diseases to compensate for the growing need to maintain eye health. In this paper, the relevant research of DTx and their application in the field of eye health were reviewed.

表1 弱视和视功能训练数字疗法类产品汇总
序号 注册证编号 注册人名称 产品名称 批准日期 有效日期
1 粤械注准20162701452 广州视景医疗软件有限公司 视觉功能训练治疗软件 2018/02/22 2023/02/21
2 粤械注准20142210073 广东盖尔伦医学发展有限公司 视觉生物信息刺激技术应用于儿童弱视的分级检查与治疗软件 2019/07/17 2024/07/16
3 京械注准20192160585 北京视源康医疗器械有限公司 综合视功能检查康复训练治疗系统 2019/09/25 2024/09/24
4 湘械注准20152210033 湖南双琦视佳医疗科技有限公司 多功能弱视治疗软件系统 2019/12/19 2024/12/18
5 粤械注准20202210139 珠海广目锐视医疗科技有限公司 视感知觉训练软件 2020/01/31 2025/01/30
6 辽械注准20202140199 沈阳倍优科技有限公司 视觉功能训练治疗软件 2020/04/26 2025/04/25
7 皖械注准20202210321 合肥科飞视觉科技有限公司 视知觉学习治疗软件 2020/06/09 2025/06/08
8 湘械注准20162210186 长沙视琦科技开发有限公司 视琦多媒体视觉训练系统 2020/10/29 2025/10/28
9 京械注准20162210965 北京嘉铖视欣数字医疗技术有限公司 弱视斜视矫治系统 2021/06/06 2026/06/07
10 沪械注准20212210502 上海思明堂生物科技股份有限公司 儿童弱视训练软件 2021/09/01 2026/08/31
11 湘械注准20212212071 长沙还原视界科技有限公司 双眼视功能训练治疗软件 2021/11/16 2026/11/15
12 湘械注准20222210270 湖南奥视医疗科技有限公司 视觉功能训练治疗软件 2022/01/29 2027/01/28
13 苏械注准20222210699 江苏觉华医疗科技有限公司 弱视视功能软件 2022/02/10 2027/02/09
14 苏械注准20222210699 江苏觉华医疗科技有限公司 弱视视功能软件 2022/02/10 2027/02/09
15 浙械注准20212210379 波克数康视觉科技(杭州)有限公司 视觉训练系统 2022/04/11 2026/08/26
16 粤械注准20222210474 广州立唯图科技有限公司 视觉功能训练治疗软件 2022/04/12 2027/04/11
17 湘械注准20222210750 精准视光(长沙)医疗科技有限公司 视觉功能训练治疗软件 2022/04/29 2027/04/28
18 湘械注准20222210975 湖南欧科生物科技有限公司 视知觉学习治疗软件 2022/06/02 2027/06/01
19 湘械注准20222211004 湖南盛视医疗科技有限公司 视觉功能训练治疗软件 2022/06/08 2027/06/07
20 粤械注准20162211452 广州视景医疗软件有限公司 视觉功能训练治疗软件 2022/09/09 2028/02/21
21 湘械注准20222211853 湖南盛视佳医疗器械有限公司 视功能训练软件 2022/10/12 2027/10/11
22 湘械注准20222212055 长沙深度视界医疗科技有限公司 双眼视感知觉功能检查与训练治疗软件 2022/11/09 2027/11/08
[1]
Hong JS, Wasden C, Han DH. Introduction of digital therapeutics[J]. Computer Methods and Programs in Biomedicine, 2021, 209: 106319.
[2]
王晓迪,罗晓斌,郭清. 数字疗法在慢性病健康管理中的应用及发展趋势[J]. 中华健康管理学杂志202216(1):51-54.
[3]
姚恒美. 全球数字疗法发展态势研究[J]. 竞争情报202218(2):57-63.
[4]
Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare[J]. Journal of Family Medicine and Primary Care, 2020, 9(5): 2207.
[5]
Digital Therapeutics Alliance. Digital Therapeutics x-Definition -and -Core -Principles[EB/OL]. [2022-01-31].

URL    
[6]
动脉网. 中国数字疗法白皮书2.0:当风轻借力,一举入高空[EB/OL].[2022-01-31].

URL    
[7]
陈杰,李雪梅. 数字疗法的现状发展与挑战[J]. 中国数字医学202116(11):94-98.
[8]
术康. 国内首个"数字疗法"获NMPA批准上市[EB/OL]. [2022-01-31].

URL    
[9]
动脉网. 中国数字疗法白皮书2.0:从研发到商业全流程挖掘关键成功因素[EB/OL]. [2022-01-29].

URL    
[10]
Yin X, Han G, Zhang H, et al. A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01)[J]. Journal of Clinical and Translational Hepatology, 2020, 8(1): 1-8.
[11]
Kollins SH, DeLoss DJ, Cañadas E, et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial[J]. The Lancet Digital Health, 2020, 2(4): e168-e178.
[12]
Maricich YA, Xiong X, Gerwien R, et al. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder[J]. Current Medical Research and Opinion, 2021, 37(2): 175-183.
[13]
Digital Therapeutics Alliance. BlueStar® and BlueStar Rx®[EB/OL]. [2022-07-11].

URL    
[14]
动脉网. The Global Digital Therapeutics Industry Report 2022[EB/OL].[2022-12-02].

URL    
[15]
Kates MM, Beal CJ. Amblyopia[J]. JAMA, 2021, 325(4): 408.
[16]
中华医学会眼科学分会斜视与小儿眼科学组,中国医师协会眼科医师分会斜视与小儿眼科学组. 中国儿童弱视防治专家共识(2021年)[J]. 中华眼科杂志202157(5):336-340.
[17]
National Eye Institute. Amblyopia (Lazy Eye) [EB/OL].[2022-01-31].

URL    
[18]
李蕾,付晶. 弱视及弱视相关双眼视功能损害治疗的新进展[J/CD]. 中华眼科医学杂志(电子版)20166(1):47-50.
[19]
中国医学装备协会眼科专业委员会眼科检验检测学组联合中国医学装备协会眼科专业委员会眼科创新诊疗技术及装备学组. 虚拟现实与增强现实设备基于视觉健康使用的专家共识(2022)[J/OL]. 中华眼科医学杂志(电子版)2022, 12(2):125-128.
[20]
Coco-Martin MB, Piñero DP, Leal-Vega L, et al. The Potential of Virtual Reality for Inducing Neuroplasticity in Children with Amblyopia[J]. Journal of Ophthalmology, 2020: 1-9.
[21]
朱敏娟,邓宏伟,陶政暘,等. 双眼视知觉网络训练对弱视治疗短期视力提升效果的临床研究[J/OL]. 中华眼科医学杂志(电子版)202010(4):226-233.
[22]
Xiao S, Gaier ED, Mazow ML, et al. Improved adherence and treatment outcomes with an engaging, personalized digital therapeutic in amblyopia[J]. Scientific Reports, 2020, 10(1): 8328.
[23]
Xiao S, Angjeli E, Wu HC, et al. Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia[J]. Ophthalmology, 2022, 129(1): 77-85.
[24]
Nova-Sight. CureSight amblyopia treatment[EB/OL]. [2022-12-01].

URL    
[25]
Wygnanski-Jaffe T, Kushner BJ, Moshkovitz A, et al. An eye-tracking-based dichoptic home treatment for amblyopia: a multicenter randomized clinical trial[J]. Ophthalmology, 2022: S0161642022008351.
[26]
赵成,鄢涛. 3D/4D数字化斜弱视视功能矫治系统联合屈光矫正及遮盖疗法治疗成人弱视[J]. 国际眼科杂志202121(11):2005-2007.
[27]
中华人民共和国中央人民政府. 2020年我国儿童青少年总体近视率为52.7%近视低龄化问题仍突出[EB/OL]. [2022-02-01].

URL    
[28]
Dopavision. OUR PRODUCT: MYOPIAX®[EB/OL]. [2022-02-06].

URL    
[29]
Dopavision GmbH. MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation[R]. NCT04967287, clinicaltrials.gov, 2021.
[30]
Schuett S, Heywood CA, Kentridge RW, et al. Rehabilitation of reading and visual exploration in visual field disorders: transfer or specificity?[J]. Brain, 2012, 135(3): 912-921.
[31]
Mannan SK, Pambakian ALM, Kennard C. Compensatory strategies following visual search training in patients with homonymous hemianopia: an eye movement study.[J]. Journal of neurology, 2010, 257(11): 1812-1821.
[32]
Sahraie A, Smania N, Zihl J. Use of NeuroEyeCoachTM to Improve Eye Movement Efficacy in Patients with Homonymous Visual Field Loss[J]. BioMed Research International, 2016: 5186461.
[33]
Inomata T, Sung J, Nakamura M, et al. Using Medical Big Data to Develop Personalized Medicine for Dry Eye Disease[J]. Cornea, 2020, 39(1): S39-S46.
[34]
Inomata T, Iwagami M, Nakamura M, et al. Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application[J]. JAMA Ophthalmology, 2020, 138(1): 58-68.
[35]
Inomata T, Nakamura M, Iwagami M, et al. Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm[J]. Ophthalmology, 2019, 126(5): 766-768.
[36]
赵慧,刘祖国,肖辛野,等. 非加热型湿房镜治疗干眼的临床疗效[J]. 中华眼视光学与视觉科学杂志201416(9):517-521.
[37]
李超,赵东卿,周丹虹,等. 干眼理疗仪治疗干眼的多中心随机对照研究[J]. 中华眼视光学与视觉科学杂志202224(5):370-376.
[38]
Li Z, Jiang J, Chen K, et al. Preventing corneal blindness caused by keratitis using artificial intelligence[J]. Nature Communications, 2021, 12(1): 3738.
[39]
Tiwari M, Piech C, Baitemirova M, et al. Differentiation of Active Corneal Infections from Healed Scars Using Deep Learning[J]. Ophthalmology, 2022, 129(2): 139-146.
[40]
Zhang Z, Wang H, Wang S, et al. Deep learning-based classification of infectious keratitis on slit-lamp images[J]. Therapeutic Advances in Chronic Disease, 2022, 13: 20406223221136071.
[41]
Wang L, Chen K, Wen H, et al. Feasibility assessment of infectious keratitis depicted on slit-lamp and smartphone photographs using deep learning[J]. International Journal of Medical Informatics, 2021, 155: 104583.
[42]
姚克. 我国白内障研究发展方向及面临的问题[J]. 中华眼科杂志201551(4):241-244.
[43]
Wu X, Huang Y, Liu Z, et al. Universal artificial intelligence platform for collaborative management of cataracts[J]. British Journal of Ophthalmology, 2019, 103(11): 1553-1560.
[44]
Lin H, Li R, Liu Z, et al. Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial[J]. EClinicalMedicine, 2019, 9: 52-59.
[45]
Zhang H, Niu K, Xiong Y, et al. Automatic cataract grading methods based on deep learning[J]. Computer Methods and Programs in Biomedicine, 2019, 182: 104978.
[46]
Tham YC, Goh JHL, Anees A, et al. Detecting visually significant cataract using retinal photograph-based deep learning[J]. Nature Aging, 2022, 2(3): 264-271.
[47]
Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma: A Review[J]. JAMA, 2014, 311(18): 1901-1911.
[48]
Guo F, Li W, Zhao X, et al. A mobile app for Glaucoma diagnosis and its possible clinical applications[J]. BMC Medical Informatics and Decision Making, 2020, 20(S3): 128.
[49]
Wright HR, Diamond JP. Service innovation in glaucoma management: using a web-based electronic patient record to facilitate virtual specialist supervision of a shared care glaucoma programme[J]. British Journal of Ophthalmology, 2015, 99(3): 313-317.
[50]
Elson MJ, Giangiacomo A, Maa AY, et al. Early Experience With Full-scope Shared-care Teleglaucoma in Canada[J]. Journal of Glaucoma, 2022, 31(2): 79-83.
[51]
Antonetti DA, Gardner TW. Diabetic Retinopathy[J]. The New England Journal of Medicine, 2012, 366(13): 1227-1239.
[52]
van der Heijden AA, Abramoff MD, Verbraak F, et al. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System[J]. Acta Ophthalmologica, 2018, 96(1): 63-68.
[53]
Ipp E, Liljenquist D, Bode B, et al. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy[J]. JAMA Network Open, 2021, 4(11): e2134254.
[54]
Rajalakshmi R, Subashini R, Anjana RM, et al. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence[J]. Eye, 2018, 32(6): 1138-1144.
[55]
Chakravarthy U, Goldenberg D, Young G, et al. Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration[J]. Ophthalmology, 2016, 123(8): 1731-1736.
[56]
Keenan TDL, Goldstein M, Goldenberg D, et al. Prospective, Longitudinal Pilot Study: Daily Self-Imaging with Patient-Operated Home OCT in Neovascular Age-Related Macular Degeneration[J]. Ophthalmology Science, 2021, 1(2): 100034.
[57]
Ho AC, Heier JS, Holekamp NM, et al. Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration[J]. Journal of Clinical Medicine, 2021, 10(7): 1355.
[1] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[2] 郁莹, 张皓, 曾晓莉, 江一巍, 易芳羽, 翁清清, 张颖. 基于风险评估的6岁儿童龋病分级管理临床效果评价[J]. 中华口腔医学研究杂志(电子版), 2020, 14(06): 345-352.
[3] 黄海. 膀胱全程数字化管理在新形势下的发展意义[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(06): 454-457.
[4] 张凯文, 刘含若. 眼健康与全身健康相互作用机制的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 119-123.
[5] 李坤徉, 张莉. 慢性阻塞性肺疾病急性加重并发糖尿病的危险因素分析[J]. 中华临床医师杂志(电子版), 2022, 16(06): 493-500.
[6] 张营, 王芳. 慢病管理模式对类风湿性关节炎患者生活质量的影响[J]. 中华临床医师杂志(电子版), 2020, 14(07): 546-551.
[7] 王宇, 关山, 张冰, 张开通, 霍昱. 乳腺癌全程管理与患者健康教育[J]. 中华临床医师杂志(电子版), 2020, 14(05): 355-358.
[8] 李昂, 陆迪菲, 刘林, 张东辉, 孙雅兰, 李君, 井路路, 王艳妮, 郭晓蕙, 张俊清. 共同照护随访队列不同病程2型糖尿病患者糖化血红蛋白达标率及自我管理能力变化分析[J]. 中华临床医师杂志(电子版), 2020, 14(03): 180-184.
[9] 张军. 妊娠合并肺动脉高压的诊治与管理策略[J]. 中华产科急救电子杂志, 2022, 11(01): 13-17.
[10] 肖湛松, 樊尚荣. 妊娠合并心脏病的筛查和管理[J]. 中华产科急救电子杂志, 2022, 11(01): 4-7.
[11] 张少凤, 沈丽霞, 吴艳欣, 陈海天. 筛查标准及管理方式对糖尿病合并妊娠诊治情况的影响[J]. 中华产科急救电子杂志, 2021, 10(01): 49-54.
[12] 陈乐锋, 戴冽. 妊娠合并未分化结缔组织病的管理[J]. 中华产科急救电子杂志, 2019, 08(02): 97-102.
[13] 黎静, 钟梅. 妊娠合并重度特发性血小板减少性紫癜的诊治[J]. 中华产科急救电子杂志, 2019, 08(02): 72-75.
[14] 林建华, 傅勤. 妊娠合并暴发性心肌炎的诊治[J]. 中华产科急救电子杂志, 2019, 08(02): 68-71.
[15] 于玲, 张祉昱, 张喆, 傅瑜. 偏头痛常见诱因及其在疾病管理中的应用研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 400-403.
阅读次数
全文


摘要